USPTO Examiner SASS KIMBERLY A - Art Unit 3686

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18666485HEALTH TRACKING SYSTEM WITH MEAL GOALSMay 2024March 2026Allow2220NoNo
18639124EVALUATION OF INGREDIENTS FOR TOXICITY WITH MACHINE LEARNINGApril 2024December 2025Abandon2010NoNo
18626099INTELLIGENT DECISION REASONING METHOD FOR TYPE-BASED DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE, DEVICE, AND PRODUCTApril 2024December 2024Allow910NoNo
18624949DIAGNOSTIC IMAGING DEEP LEARNING SYSTEM AND METHODApril 2024December 2025Abandon2010NoNo
18696720METHOD AND SYSTEM FOR COLLECTING, RECORDING, AND TRANSMITTING CLINICAL INFORMATION WITH USEFULNESS-DRIVEN PROMPTSMarch 2024March 2026Abandon2401NoNo
18602776APPARATUS AND METHOD FOR IDENTIFYING REGIONS OF INTEREST DURING SLIDE DIGITIZATIONMarch 2024September 2024Allow710YesNo
18599934Blood Donation Collection SystemMarch 2024September 2025Allow1920NoNo
18421946HEALTH TESTING AND DIAGNOSTICS PLATFORMJanuary 2024July 2025Abandon1810NoNo
18391300PRESCRIPTIVE NUTRITION-BASED IV AND IM INFUSION TREATMENT FORMULA CREATION SYSTEMS AND METHODSDecember 2023June 2025Allow1710YesNo
18525112FAILED IMAGE MANAGEMENT APPARATUS, OPERATION METHOD OF FAILED IMAGE MANAGEMENT APPARATUS, AND FAILED IMAGE MANAGEMENT SYSTEMNovember 2023February 2026Allow2630YesNo
18553314Artificial Intelligence For Determining A Patient's Disease Progression Level to Generate A Treatment PlanSeptember 2023December 2025Abandon2710NoNo
18367281METHOD FOR REPURPOSING NDC CODES IN A PHARMACEUTICAL DATABASE FOR ALLERGENSSeptember 2023January 2025Abandon1610NoNo
18219963Outcomes and Response Times for Patients in Critical Care SettingsJuly 2023September 2025Abandon2710NoNo
18342273SYSTEM AND METHODS FOR SECURING A DRUG THERAPYJune 2023August 2025Allow2530YesNo
18342155SYSTEMS AND METHODS FOR A COMPREHENSIVE ONLINE HEALTH CARE PLATFORMJune 2023October 2025Allow2730YesNo
18325812SYSTEMS, METHODS, AND DEVICES FOR VIRTUALLY SUPERVISED MEDICAL WEIGHT LOSS TREATMENT PROGRAM ADMINISTERED VIA ON-DEMAND TELEHEALTH PROCTOR-OBSERVED PLATFORMMay 2023March 2025Allow2130NoNo
18315008METHOD FOR OPERATING A SYSTEM AND A SYSTEMMay 2023June 2024Allow1310YesNo
18136136BUSINESS TO CUSTOMER COMMUNICATION PORTALApril 2023February 2026Allow3431NoNo
18165306Diabetes Management Therapy AdvisorFebruary 2023March 2024Allow1420YesNo
18103146PREDICTING RESPONSE TO IMMUNOTHERAPY TREATMENT USING DEEP LEARNING ANALYSIS OF IMAGING AND CLINICAL DATAJanuary 2023March 2024Allow1410NoNo
18083696PERIHEMATOMAL EDEMA ANALYSIS IN CT IMAGESDecember 2022November 2023Allow1010YesNo
18054732MONITORING ASSISTANCE DEVICE, MONITORING ASSISTANCE SYSTEM, MONITORING ASSISTANCE METHOD, AND STORAGE MEDIUMNovember 2022March 2026Abandon4030NoNo
17923795SYSTEM FOR TRACKING THE STATE OF A HOSPITAL RESOURCENovember 2022September 2025Abandon3510NoNo
17977711SYSTEMS AND METHODS FOR MANAGING DIABETES CARE DATAOctober 2022March 2024Allow1710NoNo
17971428SYSTEM AND METHOD FOR POINT OF CARE BASED ON REAL-TIME PREDICTION OF ADDICTION TRIGGERSOctober 2022August 2025Abandon3411NoNo
17966766EVALUATION OF COMPREHENSIVE CLINICAL RISK PROFILES OF INFECTIOUS DISEASE IN REAL-TIMEOctober 2022January 2025Abandon2710NoNo
17961898Personalised Medicine Treatment ProgramOctober 2022March 2026Abandon4120YesNo
17937874HEALTHCARE INFORMATION PROCESSING APPARATUS AND HEALTHCARE INFORMATION SERVEROctober 2022March 2026Abandon4130NoNo
17947829BLOOD DONATION COLLECTION SYSTEMSeptember 2022December 2023Allow1510YesNo
17901880CIRCUIT SYSTEM WHICH EXECUTES A METHOD FOR PREDICTING SLEEP APNEA FROM NEURAL NETWORKSSeptember 2022April 2025Abandon3210NoNo
17886957SYSTEM AND METHOD FOR PATIENT DATA PROCESSING DURING DIAGNOSIS AND THERAPYAugust 2022June 2024Allow2210YesNo
17880920PRESCRIPTIVE NUTRITION-BASED IV AND IM INFUSION TREATMENT FORMULA CREATION SYSTEMS AND METHODSAugust 2022September 2023Allow1421YesYes
17811591USER INTERFACE FOR NAVIGATING THROUGH PHYSIOLOGICAL DATAJuly 2022October 2023Abandon1620YesNo
17787589SMART DIAGNOSIS SYSTEM AND METHODJune 2022August 2025Allow3820YesNo
17804227HEALTH TESTING AND DIAGNOSTICS PLATFORMMay 2022November 2023Allow1820NoNo
17739277COMPUTERIZED METHOD FOR DETERMINING NUTRITIONAL SUPPLEMENT DELIVERYMay 2022December 2025Abandon4330NoNo
17738869IV COMPOUNDING SYSTEMS AND METHODSMay 2022November 2025Allow4240YesNo
17724472CEREBRAL HEMORRHAGE ANALYSIS IN CT IMAGESApril 2022February 2025Abandon3410NoNo
17702325GENERATION OF A TRANSACTION SETMarch 2022October 2024Allow3020YesNo
17677587HEALTH TESTING AND DIAGNOSTICS PLATFORMFebruary 2022September 2023Allow1940YesNo
17671215INDIVIDUALLY CUSTOMIZED ALLERGY CREAM FOR INDIVIDUAL PATIENT PROFILEFebruary 2022June 2025Abandon4020NoNo
17666817Medical Intelligence System and MethodFebruary 2022September 2025Allow4330YesNo
17566289Patient Post-Operation Improvement Prediction Using Machine LearningDecember 2021November 2024Abandon3510NoNo
17552867HEALTH TRACKING SYSTEM WITH MEAL GOALSDecember 2021February 2024Allow2620YesNo
17544511DEVICE AND METHOD FOR MOBILE MONITORING OF DRAINAGE CATHETERDecember 2021August 2023Allow2110YesNo
17457913INFORMATION PROCESSING APPARATUS, NON-TRANSITORY COMPUTER READABLE MEDIUM, AND INFORMATION PROCESSING METHODDecember 2021February 2026Abandon5040YesNo
17535555SETTING AN AUTOMATIC WINDOW OF INTEREST BASED ON A LEARNING DATA ANALYSISNovember 2021March 2026Abandon5250NoNo
17528089CRITERIA BASED ALARMS COORDINATION BETWEEN A NETWORK OF MEDICAL DEVICESNovember 2021June 2024Allow3110YesNo
17518006DATABASE AND MACHINE LEARNING IN RESPONSE TO PARALLEL SERIAL DUAL MICROFLUIDIC CHIPNovember 2021April 2025Abandon4111NoNo
17365142SYSTEMS AND METHODS FOR PATIENT RECORD MATCHINGJuly 2021November 2024Abandon4111NoNo
17308937ANONYMOUS DATA PUBLISHINGMay 2021October 2023Abandon3010NoNo
17200839USER INTERFACE FOR NAVIGATING THROUGH PHYSIOLOGICAL DATAMarch 2021May 2025Abandon5020NoYes
17188200TRANSFER OF BREATHING ASSISTANCE APPARATUS DATAMarch 2021March 2024Allow3720YesNo
17174743SYSTEMS AND METHODS FOR PATIENT RECORD MATCHINGFebruary 2021June 2024Abandon4010NoNo
17163893Patient Management Based On Anatomic MeasurementsFebruary 2021February 2026Abandon6060YesNo
17158145FAILED IMAGE MANAGEMENT APPARATUS, OPERATION METHOD OF FAILED IMAGE MANAGEMENT APPARATUS, AND FAILED IMAGE MANAGEMENT SYSTEMJanuary 2021August 2023Allow3110YesNo
17122003ALGORITHM ORCHESTRATION OF WORKFLOWS TO FACILITATE HEALTHCARE IMAGING DIAGNOSTICSDecember 2020February 2024Allow3830YesNo
17109458MEDICAL CARE SUPPORT APPARATUSDecember 2020March 2025Abandon5240NoNo
17108348SYSTEM AND METHOD FOR GENERATING DIFFERENTIAL DIAGNOSIS IN A HEALTHCARE ENVIRONMENTDecember 2020December 2023Abandon3610NoNo
17102595ALGORITHM ORCHESTRATION OF WORKFLOWS TO FACILITATE HEALTHCARE IMAGING DIAGNOSTICSNovember 2020August 2024Allow4540YesNo
17089702EFFICIENT DETERMINATION OF A DATA ENTITY STORING HEALTHCARE DATA THROUGH MAPPED ENTRY AND/OR TRAVERSAL OF A SEMANTIC DATA STRUCTURENovember 2020March 2024Abandon4011NoNo
17019056INTELLIGENT PROCESSING OF BULK HISTORIC PATIENT DATASeptember 2020February 2026Abandon6040YesYes
16998509SYSTEMS AND METHODS FOR PATIENT RECORD MATCHINGAugust 2020December 2023Abandon4011NoNo
16958544AUTOMATED EXTRACTION OF STRUCTURED LABELS FROM MEDICAL TEXT USING DEEP CONVOLUTIONAL NETWORKS AND USE THEREOF TO TRAIN A COMPUTER VISION MODELJune 2020January 2024Allow4220YesNo
16954568METHOD AND SYSTEM FOR EVALUATING COMPLIANCE OF STANDARD CLINICAL GUIDELINES IN MEDICAL TREATMENTSJune 2020May 2024Abandon4740YesNo
16891309RISK PREDICTION FOR COVID-19 PATIENT MANAGEMENTJune 2020September 2023Allow4030YesNo
16888104METHOD AND SYSTEM FOR REMOTELY MONITORING THE PHYSICAL AND PSYCHOLOGICAL STATE OF AN APPLICATION USER USING ALTITUDE AND/OR MOTION DATA AND ONE OR MORE MACHINE LEARNING MODELSMay 2020December 2023Allow4230NoNo
16840624System, Method and Apparatus for Performing Real-Time Virtual Medical ExaminationsApril 2020April 2024Allow4880YesNo
16832142METHOD AND SYSTEM FOR PROVIDING INTERPRETATION INFORMATION ON PATHOMICS DATAMarch 2020June 2023Allow3860YesNo
16807946COMMUNICATION MODE SELECTION BASED UPON USER CONTEXT FOR PRESCRIPTION PROCESSESMarch 2020March 2025Allow6060YesNo
16623421METHOD AND SYSTEM FOR IMAGE ANALYSIS OF A MEDICAL IMAGEDecember 2019December 2023Abandon4810NoNo
16588881Tracking the Probability for Imminent Hypoglycemia in Diabetes From Self-Monitoring Blood Glucose (SMBG) DataSeptember 2019July 2025Abandon6060YesNo
16557797METHODS AND SYSTEMS FOR COMPUTER-AIDED DIAGNOSIS WITH DEEP LEARNING MODELSAugust 2019March 2024Allow5442YesNo
16193078MANAGEMENT APPARATUS AND SYSTEMNovember 2018June 2024Abandon6080YesNo
15755096Systems And Methods For Genetic Analysis Of MetastasesFebruary 2018October 2023Allow6030YesYes
15420187Method and System for Entry, Transfer, Storage, Transmission and Retrieval of Medical, Health and Healthcare Related DataJanuary 2017January 2020Abandon3621YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SASS, KIMBERLY A..

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
3
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
18.0%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
3
(100.0%)
Filing Benefit Percentile
10.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner SASS, KIMBERLY A. - Prosecution Strategy Guide

Executive Summary

Examiner SASS, KIMBERLY A. works in Art Unit 3686 and has examined 34 patent applications in our dataset. With an allowance rate of 44.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.

Allowance Patterns

Examiner SASS, KIMBERLY A.'s allowance rate of 44.1% places them in the 9% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by SASS, KIMBERLY A. receive 3.03 office actions before reaching final disposition. This places the examiner in the 87% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SASS, KIMBERLY A. is 42 months. This places the examiner in the 19% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +59.0% benefit to allowance rate for applications examined by SASS, KIMBERLY A.. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 17.2% of applications are subsequently allowed. This success rate is in the 15% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 15.0% of cases where such amendments are filed. This entry rate is in the 16% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 25.0% of appeals filed. This is in the 3% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 114.3% are granted (fully or in part). This grant rate is in the 94% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.